TABLE 2:

Comparison Among Imaging Modalities in SUV_max Measurements

Modality	Lesions			Contralateral Adrenal Gland	Ratio of Lesion to Contralateral Adrenal Gland	Normal Liver	Ratio of Lesion to Liver
	All	True-Positives	False-Negatives
68Ga-DOTATATE PET/CT (n = 14)
Mean ± SD	43.6 ± 26.7	47.0 ± 29.3	31.3 ± 8.4	29.3 ± 12.0	1.6 ± 0.8	11.0 ± 2.4	4.2 ± 2.7
Median	35.3	36.0	34.6	29.8	1.3	10.6	3.4
Range	15.0–99.4	15.0–99.4	21.7–37.5	10.0–49.8	0.7–3.7	7.5–14.9	1.5–11.0
FDG PET/CT (n = 14)
Mean ± SD	10.5 ± 5.6	12.0 ± 5.5	5.2 ± 1.5	5.2 ± 2.6	2.3 ± 1.5	3.8 ± 1.1	3.0 ± 2.0
Median	10.2	11.0	5.6	4.5	1.7	3.7	2.5
Range	3.6–20.9	5.2–20.9	3.6–6.5	2.9–12.0	1.0–6.4	1.9–6.8	1.0–6.6
18F-FDOPA PET/CT (n = 11)
Mean ± SD	34.6 ± 21.7	34.6 ± 21.7	NAa	7.0 ± 2.1	5.7 ± 4.7	3.4 ± 0.8	10.5 ± 7.3
Median	31.2	31.2		6.7	4.9	3.2	8.3
Range	11.6–78.4	11.6–78.4		4.4–11.7	1.3–17.7	2.6–5.5	3.6–27.0
18F-FDA PET/CT (n = 7)
Mean ± SD	39.3 ± 17.7	42.4 ± 17.2	20.8 ± 0b	18.2 ± 11.0	2.5 ± 1.3	10.9 ± 2.3	3.5 ± 1.0
Median	32.4	35.5		17.2	2.0	9.8	3.3
Range	20.8–73.8	28.1–73.8		7.9–40.9	1.1–4.9	9.1–15.7	2.3–4.7

Note—NA = not applicable.

^aNo false-negatives.

^bOnly one false-negative.